Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonsecretory multiple myeloma.

Iman A Abdalla1, Imad A Tabbara

  • 1Bone Marrow Transplant Program, George Washington University Medical Center, Washington, DC 20037, USA.

Southern Medical Journal
|July 30, 2002
PubMed
Summary

Nonsecretory multiple myeloma (NSMM) is a rare multiple myeloma variant. Diagnosis is challenging as it lacks monoclonal gammopathy, unlike classic multiple myeloma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bispecific Antibodies in Multiple Myeloma: A Concise Review of Current Treatments.

Cancer investigation·2026
Same author

Targeted Therapies in Non-Small Cell Lung Cancer: A Contemporary Review.

American journal of clinical oncology·2025
Same author

Bruton Tyrosine Kinase Degraders: Current Concepts.

American journal of clinical oncology·2025
Same author

Maintenance Therapy in Acute Myeloid Leukemia.

American journal of clinical oncology·2024
Same author

PARP Inhibitors in Prostate Cancer.

Anticancer research·2021
Same author

Prognostic impact of retropharyngeal lymphadenopathy in early-stage HPV-associated oropharyngeal cancer: Implications for staging optimization.

Oral oncology·2021

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Nonsecretory multiple myeloma (NSMM) is a rare variant of classic multiple myeloma (MM), accounting for 1-5% of cases.
  • NSMM shares clinical and radiographic features with MM, but lacks detectable monoclonal gammopathy.
  • This diagnostic challenge necessitates alternative methods for identification.

Observation:

  • A case study of a 43-year-old African American woman with back pain and vertebral fractures initially misdiagnosed as osteoporosis.
  • Development of hypercalcemia prompted further investigation, leading to an NSMM diagnosis.
  • Skeletal surveys revealed diffuse osteolytic lesions, and bone marrow biopsy showed significant plasmacytosis.

Findings:

  • The patient's NSMM diagnosis was confirmed despite the absence of serum or urine monoclonal gammopathy.
  • Bone marrow biopsy was crucial in identifying marked plasmacytosis, a key indicator.
  • The study discusses current immunohistochemical and chromosomal analysis techniques for NSMM.

Implications:

  • Highlights the diagnostic difficulties associated with NSMM due to the absence of monoclonal gammopathy.
  • Emphasizes the importance of bone marrow biopsy and advanced techniques in diagnosing NSMM.
  • Contributes to understanding this rare myeloma variant and informs clinical diagnostic strategies.

Related Experiment Videos